Divisadero Street Capital Management’s Adaptive Biotechnologies ADPT Stock Holding History
Bought
Maintained
Sold
Other funds holding ADPT
VCM
VPM
Divisadero Street Capital Management's ADPT Position: Q1 2026 in Review
Divisadero Street Capital Management increased its Adaptive Biotechnologies (ADPT) stake by 265% in Q1 2026, buying an estimated $15.3M and bringing the position to 1,318,661 shares worth $18.3M. The position accounts for 0.77% of the portfolio, ranked #34.
Divisadero Street Capital Management first reported a position in ADPT in Q4 2025 and has held it in 2 quarters since. 295 funds tracked by Wall St. Rank hold ADPT as of Q1 2026.
- Divisadero Street Capital Management held 1,318,661 shares of Adaptive Biotechnologies worth $18.3M as of Q1 2026.
- Divisadero Street Capital Management bought 957,317 Adaptive Biotechnologies shares in Q1 2026, an estimated $15.3M.
- Adaptive Biotechnologies made up 0.77% of Divisadero Street Capital Management's portfolio in Q1 2026, its #34 holding.
- Divisadero Street Capital Management first reported a position in Adaptive Biotechnologies in Q4 2025 and has held it in 2 quarters since.
- 295 funds tracked by Wall St. Rank held Adaptive Biotechnologies as of Q1 2026.
Based on Divisadero Street Capital Management's 13F filing for Q1 2026, filed 15 May 2026.